The role of cholesteryl ester transfer protein and phospholipid transfer protein in the remodeling of plasma high-density lipoproteins

Trends in Cardiovascular Medicine

Volumn 7, Issue 6, 1997, Pages 218-224

  Lagrost, Laurent ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

HUMAN; LIPID ANALYSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LIPID INTERACTION; SHORT SURVEY; STRUCTURE ANALYSIS;

EID: 0030844504     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00053-4     Document Type: Review

References (59)

1. Agellon LB, Walsh A, Hayek T, et al.: 1991. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 266:10,796-10,801.
2. Albers JJ, Wolfbauer G, Cheung MC, et al.: 1995. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim Biophys Acta 1258:27-34.
3. Atger V, de la Liera Moya M, Bamberger M, et al.: 1995. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI. J Clin Invest 96:2613-2622.
4. Bagdade JD, Kaufman D, Ritter MC, Subbaiah PV: 1990. Probucol treatment in hypercholesterolemic patients: effects of lipoprotein composition, HDL particle size, and cholesteryl ester transfer. Atherosclerosis 84:145-154.
5. 2: a study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 269:11,572-11,577.
6. Barrans A, Jaspard B, Barbaras R, Chap H, Perret B, Collet X: 1996. Pre-beta HDL: structure and metabolism. Biochim Biophys Acta 1300:73-85.
7. Barter PJ, Rye KA: 1996. High density lipoproteins and coronary heart disease. Atherosclerosis 121:1-12.
8. Barter PJ, Hopkins GJ, Ha YC: 1987. The role of lipid transfer proteins in plasma lipoprotein metabolism. Am Heart J 113:538-542.
9. Barter PJ, Chang LBF, Newnham HH, Rye K-A, Rajaram OV: 1990a. The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins. Biochim Biophys Acta 1045:81-89.
10. Barter PJ, Chang LBF, Rajaram OV: 1990b. Sodium oleate dissociates the heteroexchange of cholesteryl esters and triacylglycerol between HDL and triacylglycerol-rich lipoproteins. Biochim Biophys Acta 1047:294-297.
11. Blanche PJ, Gong EL, Forte TM, Nichols AV: 1981. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 665:408-419.
12. Brown ML, Inazu A, Hesler CB, et al.: 1989. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342:448-451.
13. Chajek-Shaul T, Hayek T, Walsh A, Breslow JL: 1991. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Proc Natl Acad Sci USA 88:6731-6735.
14. Cheung MC, Nichols AV, Blanche PJ, Gong EL, Franceschini G, Sirtori CR: 1988. Characterization of A-I-containing lipoproteins in subjects with A-I Milano variant. Biochim Biophys Acta 960:73-82.
15. Cheung MC, Brown BG, Wolf A, Albers JJ: 1991. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32:383-394.
16. Clay MA, Newnham HH, Forte TM, Barter PJ: 1992. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1124:52-58.
17. Duverger N, Rader D, Duchateau P, Fruchart J-C, Castro G, Brewer HB Jr: 1993. Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma. Biochemistry 32: 12,372-12,379.
18. Duverger N, Rader D, Brewer HB: 1994. Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women. Arterioscler Thromb 14:1594-1599.
19. Eisenberg S: 1984. High density lipoprotein metabolism. J Lipid Res 25:1017-1058.
20. Föger B, Luef G, Titsch A, et al.: 1995. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J Mol Med 73:369-372.
21. Francone OL, Royer L, Haghpassand M: 1996. Increased pre-beta HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J Lipid Res 37:1268-1277.
22. Fruchart JC, Ailhauld G: 1992. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem 38:793-797.
23. Goldberg CS, Tall AR, Krumholz S: 1984. Acute inhibition of hepatic lipase and increase in plasma lipoproteins after alcohol intake. J Lipid Res 25:714-720.
24. Guérin M, Dolphin PJ, Talussot C, Gardette J, Berthézène F, Chapman MJ: 1995. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 15:1359-1368.
25. Hayek T, Chajek-Shaul T, Walsh A, et al: 1992. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. J Clin Invest 90:505-510.
26. Hayek T, Azrolan N, Verdery RB, et al.: 1993. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism: studies in transgenic mice. J Clin Invest 92:1143-1152.
27. Hopkins GJ, Barter PJ: 1986. Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins. J Lipid Res 27: 1265-1277.
28. Hopkins GJ, Chang LBF, Barter PJ: 1985. Role of lipid transfers in the formation of a subpopulation of small high density lipoproteins. J Lipid Res 26:218-229.
29. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C: 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268:4032-4036.
30. Jiang X-C, Francone OL, Bruce C, et al.: 1996. Increased preβ-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest 98:2373-2380.
31. Johansson J, Carlson LA, Landou C, Hamsten A: 1991. High density lipoproteins and coronary atherosclerosis: a strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11:174-182.
32. Koizumi J, Mabuchi H, Yoshimura A, et al.: 1985. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinemia. Atherosclerosis 58: 175-186.
33. Kunitake ST, Mendel CM, Hennessy LK: 1992. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res 33: 1807-1816.
34. Lacko AG: 1994. The metabolism of high-density lipoproteins. Trends Cardiovasc Med 4:84-88.
35. Lagrost L: 1994. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1215:209-236.
36. Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P: 1993. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb 13:815-825.
37. Lagrost L, Athias A, Gambert P, Lallemant C: 1994. Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J Lipid Res 35:825-835.
38. Lagrost L, Athias A, Herbeth B, et al.: 1996. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins: physiological relevance in alcoholic patients. J Biol Chem 271:19,058-19,065.
39. Lusa S, Jauhiainen M, Metso J, Somerharju P, Ehnholm C: 1996. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem 1313:275-282.
40. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW: 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364:73-75.
41. Melchior GW, Castle CK, Murray RW, Blake WL, Dinh DM, Marotti KR: 1994. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice: insights into the mechanisms responsible for low plasma high density lipoprotein levels. J Biol Chem 269:8044-8051.
42. Nichols AV, Blanche PJ, Gong EL, Shore VG, Forte TM: 1985. Molecular pathways in the transformation of model discoidal lipoprotein complexes induced by lecithin:cholesterol acyltransferase. Biochim Biophys Acta 834:285-300.
43. Nichols AV, Gong EL, Blanche PJ, Forte TM, Shore VG: 1987. Pathways in the formation of human plasma high density subpopulations containing apolipoprotein A-I without apolipoprotein A-II. J Lipid Res 28:719-732.
44. Pulcini T, Terru P, Sparrow JT, Pownall HJ, Ponsin G: 1995. Plasma factors affecting the in vitro conversion of high-density lipoproteins labeled with a non-transferable marker. Biochim Biophys Acta 1254:13-21.
45. Pussinen P, Jauhiainen M, Metso J, Tyynelä J, Ehnholm C: 1995. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res 36:975-985.
46. Rader DJ, Castro G, Zech LA, Fruchart J-C, Brewer HB Jr: 1991. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-A-I,A-II. J Lipid Res 32:1849-1859.
47. Rubin EM, Ishida BY, Clift SM, Krauss RM: 1991. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci USA 88:434-438.
48. Rye K-A, Hime NJ, Barter PJ: 1995. The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins. J Biol Chem 270:189-196.
49. Schultz JR, Gong EL, McGall MR, Nichols AV, Clift SM, Rubin EM: 1992. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J Biol Chem 267:21,630-21,636.
50. Tall AR: 1995. Plasma lipid transfer proteins. Annu Rev Biochem 64:235-257.
51. Tall AR, Krumholz S, Olivecrona T, Deckelbaum RJ: 1985. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J Lipid Res 26:842-851.
52. Tu A-Y, Nishida HI, Nishida T: 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 268:23,098-23,105.
53. Valimäki M, Kahri J, Laitinen K, et al.: 1993. High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesteryl ester transfer protein activity in alcoholic women before and after ethanol withdrawal. Eur J Clin Invest 23:406-417.
54. Verdery RB, Benham DF, Baldwin HL, Goldberg AP, Nichols AV: 1989. Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels. J Lipid Res 30:1085-1095.
55. 1-HDL. Biochim Biophys Acta 1301:255-262.
56. Yamashita S, Sprecher DL, Sakai N, et al.: 1990. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest 86:688-695.
57. Yamashita S, Hui DY, Wetterau JR, et al.: 1991. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism 40:756-763.
58. Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall AR: 1994. Human apoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest 94:2457-2467.
59. Zhong S, Sharp DS, Grove JS, et al.: 1996. Increased coronary heart disease in japanese-american men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97: 2917-2923.